| __timestamp | Dr. Reddy's Laboratories Limited | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 72049000 |
| Thursday, January 1, 2015 | 62786000000 | 110777000 |
| Friday, January 1, 2016 | 62427000000 | 156328000 |
| Sunday, January 1, 2017 | 62453000000 | 175820000 |
| Monday, January 1, 2018 | 65724000000 | 143944000 |
| Tuesday, January 1, 2019 | 70421000000 | 160152000 |
| Wednesday, January 1, 2020 | 80591000000 | 188519000 |
| Friday, January 1, 2021 | 86645000000 | 258234000 |
| Saturday, January 1, 2022 | 100551000000 | 311103000 |
| Sunday, January 1, 2023 | 42907000000 | 384447000 |
| Monday, January 1, 2024 | 115557000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical landscape, understanding cost efficiency is crucial. Dr. Reddy's Laboratories Limited, a prominent player in the global market, has consistently demonstrated robust cost management. From 2014 to 2023, Dr. Reddy's Laboratories saw a 105% increase in cost of revenue, peaking in 2024. This reflects their strategic expansion and operational efficiency.
In contrast, HUTCHMED (China) Limited, a rising star in the industry, has shown a more modest growth trajectory. Their cost of revenue increased by approximately 434% from 2014 to 2023, indicating a significant scaling of operations. However, data for 2024 is missing, leaving room for speculation on their future performance.
This comparison highlights the diverse strategies employed by pharmaceutical giants in managing costs, with Dr. Reddy's focusing on steady growth and HUTCHMED on rapid expansion.
Cost of Revenue: Key Insights for Johnson & Johnson and HUTCHMED (China) Limited
Cost of Revenue Trends: AstraZeneca PLC vs HUTCHMED (China) Limited
Cost of Revenue Trends: Incyte Corporation vs Dr. Reddy's Laboratories Limited
Cost of Revenue Trends: Viatris Inc. vs HUTCHMED (China) Limited
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Alkermes plc
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs MorphoSys AG
Dr. Reddy's Laboratories Limited vs Amphastar Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.
Corcept Therapeutics Incorporated vs HUTCHMED (China) Limited: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Perrigo Company plc and HUTCHMED (China) Limited
Cost of Revenue Comparison: HUTCHMED (China) Limited vs Xencor, Inc.